Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy

BackgroundThe present work evaluated how Peking prognostic score (PPS), the new prognostic index determined according to sarcopenia and lymphocyte-to-C-reactive protein ratio (LCR), was a prognostic factor for patients with gastric cancer liver metastases (GCLM) who received hepatectomy.MethodsThis...

Full description

Bibliographic Details
Main Authors: Jianping Xiong, Yunzi Wu, Haitao Hu, Wenzhe Kang, Yang Li, Peng Jin, Xinxin Shao, Weikun Li, Yibin Xie, Yantao Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2022.976364/full
_version_ 1811253792348307456
author Jianping Xiong
Yunzi Wu
Haitao Hu
Wenzhe Kang
Yang Li
Peng Jin
Xinxin Shao
Weikun Li
Yibin Xie
Yantao Tian
author_facet Jianping Xiong
Yunzi Wu
Haitao Hu
Wenzhe Kang
Yang Li
Peng Jin
Xinxin Shao
Weikun Li
Yibin Xie
Yantao Tian
author_sort Jianping Xiong
collection DOAJ
description BackgroundThe present work evaluated how Peking prognostic score (PPS), the new prognostic index determined according to sarcopenia and lymphocyte-to-C-reactive protein ratio (LCR), was a prognostic factor for patients with gastric cancer liver metastases (GCLM) who received hepatectomy.MethodsThis work extracted information about patients with GCLM who underwent hepatectomy from June 2012 to May 2018. The PPS of the patients was calculated from sarcopenia status and LCR before surgery, and patients were then divided into three groups based on their PPS. This work also carried out univariate and multivariate analyses for identifying variables that were linked with overall survival (OS) together with recurrence-free survival (RFS) after hepatectomy among three groups according to PPS.ResultsThis work included 108 GCLM cases who received hepatectomy. All cases were classified into 3 groups, i.e., 26 (24.1%), 48 (44.4%), and 34 (31.5%) in groups 0–2, separately. PPS exhibited positive relation with age (p < 0.001), body mass index (BMI; p = 0.012), and liver metastasis number. The relapse rate after hepatectomy in patients with GCLM was 69.4%. Additionally, the remnant liver relapse rates of groups 0–2 were 80.0, 68.7, and 53.5%. Patients in group 0 had significantly increased remnant liver relapse rates when compared with those in groups 0 and 1. PPS was significantly related to relapse patterns (p = 0.003). Relative to group 0, those of the other 2 groups showed dismal OS [hazard ratio (HR) = 3.98, 7.49 for groups 1 and 2; p < 0.001] along with RFS (HR = 3.65, 5.33 for groups 1 and 2; p < 0.001). As revealed by multivariate analysis, PPS independently predicted OS (p < 0.001) together with RFS (p < 0.001).ConclusionThe PPS could be an easy nutrition-inflammation prognostic scoring system and an independent preoperative predictor of survival for GCLM cases after hepatectomy.
first_indexed 2024-04-12T16:56:38Z
format Article
id doaj.art-4e1680c0aebf4ae08d6840f00ac08511
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-12T16:56:38Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-4e1680c0aebf4ae08d6840f00ac085112022-12-22T03:24:12ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2022-09-01910.3389/fnut.2022.976364976364Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomyJianping XiongYunzi WuHaitao HuWenzhe KangYang LiPeng JinXinxin ShaoWeikun LiYibin XieYantao TianBackgroundThe present work evaluated how Peking prognostic score (PPS), the new prognostic index determined according to sarcopenia and lymphocyte-to-C-reactive protein ratio (LCR), was a prognostic factor for patients with gastric cancer liver metastases (GCLM) who received hepatectomy.MethodsThis work extracted information about patients with GCLM who underwent hepatectomy from June 2012 to May 2018. The PPS of the patients was calculated from sarcopenia status and LCR before surgery, and patients were then divided into three groups based on their PPS. This work also carried out univariate and multivariate analyses for identifying variables that were linked with overall survival (OS) together with recurrence-free survival (RFS) after hepatectomy among three groups according to PPS.ResultsThis work included 108 GCLM cases who received hepatectomy. All cases were classified into 3 groups, i.e., 26 (24.1%), 48 (44.4%), and 34 (31.5%) in groups 0–2, separately. PPS exhibited positive relation with age (p < 0.001), body mass index (BMI; p = 0.012), and liver metastasis number. The relapse rate after hepatectomy in patients with GCLM was 69.4%. Additionally, the remnant liver relapse rates of groups 0–2 were 80.0, 68.7, and 53.5%. Patients in group 0 had significantly increased remnant liver relapse rates when compared with those in groups 0 and 1. PPS was significantly related to relapse patterns (p = 0.003). Relative to group 0, those of the other 2 groups showed dismal OS [hazard ratio (HR) = 3.98, 7.49 for groups 1 and 2; p < 0.001] along with RFS (HR = 3.65, 5.33 for groups 1 and 2; p < 0.001). As revealed by multivariate analysis, PPS independently predicted OS (p < 0.001) together with RFS (p < 0.001).ConclusionThe PPS could be an easy nutrition-inflammation prognostic scoring system and an independent preoperative predictor of survival for GCLM cases after hepatectomy.https://www.frontiersin.org/articles/10.3389/fnut.2022.976364/fullgastric cancerliver metastaseshepatectomyPeking prognostic scoreprognostic scoring system
spellingShingle Jianping Xiong
Yunzi Wu
Haitao Hu
Wenzhe Kang
Yang Li
Peng Jin
Xinxin Shao
Weikun Li
Yibin Xie
Yantao Tian
Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
Frontiers in Nutrition
gastric cancer
liver metastases
hepatectomy
Peking prognostic score
prognostic scoring system
title Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
title_full Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
title_fullStr Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
title_full_unstemmed Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
title_short Peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
title_sort peking prognostic score is a useful prognostic factor in patients with gastric cancer liver metastases receiving hepatectomy
topic gastric cancer
liver metastases
hepatectomy
Peking prognostic score
prognostic scoring system
url https://www.frontiersin.org/articles/10.3389/fnut.2022.976364/full
work_keys_str_mv AT jianpingxiong pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT yunziwu pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT haitaohu pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT wenzhekang pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT yangli pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT pengjin pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT xinxinshao pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT weikunli pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT yibinxie pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy
AT yantaotian pekingprognosticscoreisausefulprognosticfactorinpatientswithgastriccancerlivermetastasesreceivinghepatectomy